Last week our chart of the week was a look at the total number of clinical trials started annually that include biomarkers, with a projection out to 2020. The hockey stick shape of the growth rate was striking, so much so that we decided to follow-up and ask the question: are there actually new and unique biomarkers being used in these trials, or are the same biomarkers being used again and again?
So this week we ran an analysis out of BiomarkerBase of the number of unique biomarkers that have been measured in clinical trials each year, and the results are pretty remarkable. Over 700 unique biomarkers were measured in clinical trials started during 2015, and if the current growth rate continues, over 50% more will be used five years from now.
Share this Image On Your Site
Please include attribution to amplion.com with this graphic.
